Oxford Nanopore Technologies plc (LON:ONT – Get Free Report)’s share price dropped 10.2% during mid-day trading on Monday . The company traded as low as GBX 127 ($1.59) and last traded at GBX 128.50 ($1.61). Approximately 3,354,197 shares changed hands during trading, an increase of 54% from the average daily volume of 2,182,529 shares. The stock had previously closed at GBX 143.10 ($1.79).
Wall Street Analysts Forecast Growth
A number of analysts have recently weighed in on the stock. Berenberg Bank restated a “buy” rating and issued a GBX 282 ($3.54) price objective on shares of Oxford Nanopore Technologies in a research note on Tuesday, September 3rd. JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Oxford Nanopore Technologies in a research note on Friday, December 6th. Finally, Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a GBX 190 ($2.38) price objective on shares of Oxford Nanopore Technologies in a research report on Wednesday, September 4th. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, Oxford Nanopore Technologies currently has an average rating of “Buy” and an average target price of GBX 235.50 ($2.95).
Read Our Latest Research Report on Oxford Nanopore Technologies
Oxford Nanopore Technologies Stock Up 5.3 %
Insider Buying and Selling
In related news, insider Gurdial (Gordon) Sanghera sold 1,993,571 shares of the company’s stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of GBX 142 ($1.78), for a total value of £2,830,870.82 ($3,548,791.30). Insiders have bought a total of 310 shares of company stock valued at $45,010 over the last three months. 32.62% of the stock is owned by corporate insiders.
Oxford Nanopore Technologies Company Profile
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.
Further Reading
- Five stocks we like better than Oxford Nanopore Technologies
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- Stock Sentiment Analysis: How it Works
- 2 Drone Stocks Surging from Increased Media Attention
- Financial Services Stocks Investing
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Oxford Nanopore Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Nanopore Technologies and related companies with MarketBeat.com's FREE daily email newsletter.